Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-13-002892
Accepted
2013-10-07 00:15:15
Documents
1
Effectiveness Date
2013-10-04
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-13-002892.txt   1734
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-191434 | Film No.: 131137830
SIC: 2834 Pharmaceutical Preparations